155 related articles for article (PubMed ID: 36871260)
1. [The challenge of the age of hepatitis C virus elimination: why is HCV vaccination necessary?].
Pár A
Orv Hetil; 2023 Mar; 164(9):322-331. PubMed ID: 36871260
[TBL] [Abstract][Full Text] [Related]
2. Modeling indicates efficient vaccine-based interventions for the elimination of hepatitis C virus among persons who inject drugs in metropolitan Chicago.
Echevarria D; Gutfraind A; Boodram B; Layden J; Ozik J; Page K; Cotler SJ; Major M; Dahari H
Vaccine; 2019 May; 37(19):2608-2616. PubMed ID: 30962092
[TBL] [Abstract][Full Text] [Related]
3. [Hepatitis C virus infection and hepatocarcinogenesis].
Berta E; Egresi A; Bacsárdi A; Gáspár Z; Lengyel G; Hagymási K
Orv Hetil; 2019 Jun; 160(22):846-853. PubMed ID: 31131608
[TBL] [Abstract][Full Text] [Related]
4. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
[TBL] [Abstract][Full Text] [Related]
5. THE GORDON WILSON LECTURE: THE HEPATITIS C VIRUS: FROM HIPPOCRATES TO CURE.
Alter HJ
Trans Am Clin Climatol Assoc; 2019; 130():104-118. PubMed ID: 31516174
[TBL] [Abstract][Full Text] [Related]
6. Factors associated with treatment failure of direct-acting antivirals for chronic hepatitis C: A real-world nationwide hepatitis C virus registry programme in Taiwan.
Chen CY; Huang CF; Cheng PN; Tseng KC; Lo CC; Kuo HT; Huang YH; Tai CM; Peng CY; Bair MJ; Chen CH; Yeh ML; Lin CL; Lin CY; Lee PL; Chong LW; Hung CH; Huang JF; Yang CC; Hu JT; Lin CW; Chen CT; Wang CC; Su WW; Hsieh TY; Lin CL; Tsai WL; Lee TH; Chen GY; Wang SJ; Chang CC; Mo LR; Yang SS; Wu WC; Huang CS; Hsiung CK; Kao CN; Tsai PC; Liu CH; Lee MH; Liu CJ; Dai CY; Kao JH; Chuang WL; Lin HC; Yu ML
Liver Int; 2021 Jun; 41(6):1265-1277. PubMed ID: 33655714
[TBL] [Abstract][Full Text] [Related]
7. [Elimination of hepatitis C virus in Denmark].
Døssing A; Røge BT; Madsen LG; Laursen AL; Hansen JB; Bukh J; Weis N
Ugeskr Laeger; 2020 Feb; 182(9):. PubMed ID: 32138816
[TBL] [Abstract][Full Text] [Related]
8. Priming of Antiviral CD8 T Cells without Effector Function by a Persistently Replicating Hepatitis C-Like Virus.
Hartlage AS; Walker CM; Kapoor A
J Virol; 2020 May; 94(10):. PubMed ID: 32102885
[TBL] [Abstract][Full Text] [Related]
9. Reverse inflammaging: Long-term effects of HCV cure on biological age.
Oltmanns C; Liu Z; Mischke J; Tauwaldt J; Mekonnen YA; Urbanek-Quaing M; Debarry J; Maasoumy B; Wedemeyer H; Kraft ARM; Xu CJ; Cornberg M
J Hepatol; 2023 Jan; 78(1):90-98. PubMed ID: 36152762
[TBL] [Abstract][Full Text] [Related]
10. [New era in the treatment of chronic hepatitis C - novel direct acting antivirals].
Horváth G; Halász T; Makara M; Hunyady B
Orv Hetil; 2015 May; 156(21):841-8. PubMed ID: 26038991
[TBL] [Abstract][Full Text] [Related]
11. [The impact of direct-acting antiviral therapy on the diagnosis of hepatitis-C virus-associated hepatocellular carcinoma].
Takahashi A; Shima T; Kinoshita N; Yano K; Ueno T; Nishiwaki M; Yamamoto Y; Oya H; Amano I; Matsumoto J; Mitsumoto Y; Tanaka I; Sakai K; Sawai N; Mizuno C; Mizuno M; Itoh Y; Okanoue T
Nihon Shokakibyo Gakkai Zasshi; 2018; 115(2):184-194. PubMed ID: 29459562
[TBL] [Abstract][Full Text] [Related]
12. Benefits of hepatitis C cure with antivirals: why test and treat?
Lledó G; Benítez-Gutiérrez L; Arias A; Requena S; Cuervas-Mons V; de Mendoza C
Future Microbiol; 2019 Mar; 14():425-435. PubMed ID: 30900911
[TBL] [Abstract][Full Text] [Related]
13. Hepatitis C: Standard of Treatment and What to Do for Global Elimination.
Di Marco L; La Mantia C; Di Marco V
Viruses; 2022 Feb; 14(3):. PubMed ID: 35336911
[TBL] [Abstract][Full Text] [Related]
14. Dehydrojuncusol, a Natural Phenanthrene Compound Extracted from
Sahuc ME; Sahli R; Rivière C; Pène V; Lavie M; Vandeputte A; Brodin P; Rosenberg AR; Dubuisson J; Ksouri R; Rouillé Y; Sahpaz S; Séron K
J Virol; 2019 May; 93(10):. PubMed ID: 30842319
[TBL] [Abstract][Full Text] [Related]
15. Persistent hepatitis C viral replication despite priming of functional CD8+ T cells by combined therapy with a vaccine and a direct-acting antiviral.
Callendret B; Eccleston HB; Satterfield W; Capone S; Folgori A; Cortese R; Nicosia A; Walker CM
Hepatology; 2016 May; 63(5):1442-54. PubMed ID: 26513111
[TBL] [Abstract][Full Text] [Related]
16. Current hepatitis C therapy.
Husa P; Snopková S; Husa Ml P
Cas Lek Cesk; 2022; 161(2):90-93. PubMed ID: 35728965
[TBL] [Abstract][Full Text] [Related]
17. Direct antiviral agents in hepatitis C virus related liver disease: Don't count the chickens before they're hatched.
Compagnoni S; Bruno EM; Madonia G; Cannizzaro M; Madonia S
World J Gastroenterol; 2021 Jun; 27(21):2771-2783. PubMed ID: 34135553
[TBL] [Abstract][Full Text] [Related]
18. The case for a universal hepatitis C vaccine to achieve hepatitis C elimination.
Scott N; Wilson DP; Thompson AJ; Barnes E; El-Sayed M; Benzaken AS; Drummer HE; Hellard ME
BMC Med; 2019 Sep; 17(1):175. PubMed ID: 31530275
[TBL] [Abstract][Full Text] [Related]
19. [Significance of hepatitis C virus baseline polymorphism during the antiviral therapy].
Tornai I
Orv Hetil; 2015 May; 156(21):849-54. PubMed ID: 26038992
[TBL] [Abstract][Full Text] [Related]
20. The curing regimens of HCV: A SWOT analysis.
Cornberg M; Manns MP
Antivir Ther; 2022; 27(1-2):13596535211072672. PubMed ID: 35491553
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]